SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-020110
Filing Date
2023-11-02
Accepted
2023-11-02 20:47:23
Documents
2
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14155
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4709
  Complete submission text file 0000899243-23-020110.txt   20212
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address
WINDSOR JAMES BRIAN (Reporting) CIK: 0001790933 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 231374204